M Margaret Kemeny. Show Affiliations »
Abstract
Entities: Species
Mesh： See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAntineoplastic Agents/adverse effectsBevacizumabColorectal Neoplasms/drug therapyColorectal Neoplasms/pathologyHepatectomyHumansInfections/chemically inducedInfections/etiologyLiver Neoplasms/drug therapyLiver Neoplasms/secondaryLiver Neoplasms/surgeryPostoperative Complications/chemically inducedPostoperative Complications/etiologySurgical Wound Dehiscence/chemically inducedSurgical Wound Dehiscence/etiologySurgical Wound Infection/chemically inducedSurgical Wound Infection/etiology
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBevacizumab
Year: 2009 PMID： 19255303 DOI： 10.1200/JCO.2008.21.2811
Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544